Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Urinary nerve growth factor levels could be a biomarker for overactive bladder symptom: a meta-analysis.

Qu HC, Yan S, Zhang XL, Zhu XW, Liu YL, Wang P.

Genet Mol Res. 2014 Apr 14;13(4):8609-19. doi: 10.4238/2014.April.14.14.

2.

The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding.

Ergin G, Kibar Y, Ebiloğlu T, Irkılata HC, Kopru B, Kaya E, Uyanık M, Tapan S, Dayanc MM.

J Pediatr Urol. 2016 Apr;12(2):118.e1-6. doi: 10.1016/j.jpurol.2015.09.015. Epub 2015 Nov 22.

PMID:
26701107
3.

Urinary nerve growth factor could be a biomarker for interstitial cystitis/painful bladder syndrome: a meta-analysis.

Qu HC, Zhang W, Yan S, Liu YL, Wang P.

PLoS One. 2014 Sep 2;9(9):e106321. doi: 10.1371/journal.pone.0106321. eCollection 2014.

4.

NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome.

Kim SR, Moon YJ, Kim SK, Bai SW.

Yonsei Med J. 2015 Jan;56(1):204-11. doi: 10.3349/ymj.2015.56.1.204.

5.

Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.

Liu HT, Kuo HC.

Urology. 2008 Jul;72(1):104-8; discussion 108. doi: 10.1016/j.urology.2008.01.069. Epub 2008 Apr 8.

PMID:
18400272
6.

Urinary nerve growth factor level is correlated with the severity of neurological impairment in patients with cerebrovascular accident.

Liu HT, Liu AB, Chancellor MB, Kuo HC.

BJU Int. 2009 Oct;104(8):1158-62. doi: 10.1111/j.1464-410X.2009.08533.x. Epub 2009 Mar 30.

7.

Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.

Kuo HC, Liu HT, Chancellor MB.

Neurourol Urodyn. 2010 Mar;29(3):482-7. doi: 10.1002/nau.20741.

PMID:
19367641
8.

Sacral nerve stimulation reduces elevated urinary nerve growth factor levels in women with symptomatic detrusor overactivity.

Shalom DF, Pillalamarri N, Xue X, Kohn N, Lind LR, Winkler HA, Metz CN.

Am J Obstet Gynecol. 2014 Nov;211(5):561.e1-5. doi: 10.1016/j.ajog.2014.07.007. Epub 2014 Jul 11.

PMID:
25019486
9.

Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder.

Liu HT, Kuo HC.

J Urol. 2008 Jun;179(6):2270-4. doi: 10.1016/j.juro.2008.01.146. Epub 2008 Apr 18.

PMID:
18423678
10.

Urinary nerve growth factor in children with overactive bladder: a promising, noninvasive and objective biomarker.

Oktar T, Kocak T, Oner-Iyidogan Y, Erdem S, Seyithanoglu M, Ziylan O, Kocak H.

J Pediatr Urol. 2013 Oct;9(5):617-21. doi: 10.1016/j.jpurol.2012.06.003. Epub 2012 Jul 11.

PMID:
22789557
11.

Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?

Seth JH, Sahai A, Khan MS, van der Aa F, de Ridder D, Panicker JN, Dasgupta P, Fowler CJ.

BJU Int. 2013 Mar;111(3):372-80. doi: 10.1111/j.1464-410X.2012.11672.x. Review.

12.
13.

Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy.

Liu HT, Lin H, Kuo HC.

Neurourol Urodyn. 2011 Nov;30(8):1525-9. doi: 10.1002/nau.21118. Epub 2011 Aug 8.

PMID:
21826717
14.

Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder.

Chung SD, Liu HT, Lin H, Kuo HC.

Neurourol Urodyn. 2011 Mar;30(3):417-20. doi: 10.1002/nau.20938. Epub 2011 Jan 31.

PMID:
21284020
15.

Urinary nerve growth factor in women with overactive bladder syndrome.

Liu HT, Chen CY, Kuo HC.

BJU Int. 2011 Mar;107(5):799-803. doi: 10.1111/j.1464-410X.2010.09585.x. Epub 2010 Aug 26.

16.

Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder.

Liu HT, Chancellor MB, Kuo HC.

BJU Int. 2009 Jun;103(12):1668-72. doi: 10.1111/j.1464-410X.2009.08380.x. Epub 2009 Feb 11.

17.

Urinary nerve growth factor correlates with the severity of urgency and pain.

Kim SW, Im YJ, Choi HC, Kang HJ, Kim JY, Kim JH.

Int Urogynecol J. 2014 Nov;25(11):1561-7. doi: 10.1007/s00192-014-2424-8. Epub 2014 May 28.

PMID:
24866276
18.

Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder.

Wang LW, Han XM, Chen CH, Ma Y, Hai B.

Int Urol Nephrol. 2014 Feb;46(2):341-7. doi: 10.1007/s11255-013-0540-x. Epub 2013 Aug 28.

PMID:
23982767
19.

Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients.

Jacobs BL, Smaldone MC, Tyagi V, Philips BJ, Jackman SV, Leng WW, Tyagi P.

Can J Urol. 2010 Feb;17(1):4989-94.

PMID:
20156378
20.

Supplemental Content

Support Center